BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Rigel Announces Conference Call and Webcast to Report Third Quarter 2017 Financial Results

  Rigel today announced that it will report its third quarter financial results after market close on Tuesday, November 7, 2017.

  October 31, 2017

   · 

  1 min read
• Business

  Bio-Techne Releases First Quarter Fiscal 2018 Results

  First quarter organic revenue increased by 8% to $144.6M.

  October 31, 2017

   · 

  24 min read
• Business

  Bio-Techne Corp. Declares Dividend

  The quarterly dividend will be payable November 24, 2017 to all common shareholders of record on November 10, 2017.

  October 31, 2017

   · 

  1 min read
• Drug Development

  MabVax Therapeutics Provides Update on the MVT-5873 Phase I Clinical Program and Expansion of Preclinical Development Pipeline at the AACR-NCI-EORTC International Conference

  Three posters were presented by Paul W. Maffuid, Ph.D., Executive VP of R&D, outlining important progress in the Company’s lead fully human antibody programs which included HuMab-5B1 currently in Phase I clinical development for the treatment of pancreatic cancer and other CA19-9 positive malignancies.

  October 31, 2017

   · 

  6 min read
• Drug Development

  Agile Therapeutics Presents Additional Phase III SECURE Trial Results for Twirla at the ASRM Scientific Congress Expo 2017

  Agile Therapeutics today announced additional data from its Phase III SECURE trial of Twirla which showed women experienced mean decreases in length of bleeding and spotting episodes.

  October 31, 2017

   · 

  6 min read
• Policy

  Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich Ataxia

  The EC’s approval follows a positive opinion in July 2017 from the European Medicine Agency’s (EMA) Committee for Orphan Medicinal Products (COMP).

  October 31, 2017

   · 

  5 min read
• BioCapital

  Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek™ 2017

  Now, Ethicon is partnering with Johnson & Johnson Health & Wellness Solutions to introduce a new digital platform and smartphone app offering resources and decision-making tools for patients considering weight loss surgery

  October 31, 2017

   · 

  8 min read
• Heska Extends Product Line With New Element COAG Veterinary Analyzer

  Heska announced today the release of the new Element COAG Veterinary Analyzer.

  October 31, 2017

   · 

  3 min read
• Biotech Beach

  Inhibrx Wins CARB-X Award of Up to $6M To Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections

  InhibRx announced today a significant collaboration with CARB-X.

  October 31, 2017

   · 

  3 min read
• Business

  InfuSystem to Issue Third Quarter 2017 Financial Results on Friday, November 10, 2017, Before the Market Opens

  The Company will also conduct a conference call for all interested investors on Friday, November 10, 2017, at 11:00 a.m.

  October 31, 2017

   · 

  1 min read